UB Paderborn / Katalog / Suche / in CDI

Isotonitazene Quantitation and Metabolite Discovery in Authentic Forensic Casework

Journal of analytical toxicology, 2020-07, Vol.44 (6), p.521-530

2020

Volltextzugriff (PDF)

Analysis of Novel Synthetic Opioids U-47700, U-50488 and Furanyl Fentanyl by LC-MS/MS in Postmortem Casework

Journal of analytical toxicology, 2016-11, Vol.40 (9), p.709-717

2016

Volltextzugriff (PDF)

Brorphine—Investigation and quantitation of a new potent synthetic opioid in forensic toxicology casework using liquid chromatography‐mass spectrometry

Journal of forensic sciences, 2021-03, Vol.66 (2), p.664-676

2021

Volltextzugriff (PDF)

Xylazine: Pharmacology Review and Prevalence and Drug Combinations in Forensic Toxicology Casework

Journal of analytical toxicology, 2022-10, Vol.46 (8), p.911-917

2022

Volltextzugriff (PDF)

Are Postmortem Cannabinoid Concentrations Forensically Reliable?

The American journal of forensic medicine and pathology, 2024-03, Vol.45 (1), p.92

2024

Volltextzugriff (PDF)

Reports of Adverse Events Associated with Use of Novel Psychoactive Substances, 2013–2016: A Review

Journal of analytical toxicology, 2017-09, Vol.41 (7), p.573-610

2017

Volltextzugriff (PDF)

Postmortem toxicology findings from the Camden Opioid Research Initiative

PloS one, 2023-11, Vol.18 (11), p.e0292674-e0292674

2023

Volltextzugriff (PDF)

The Evolving Landscape of Designer Drugs

Methods in molecular biology (Clifton, N.J.), 2019, Vol.1872, p.129

2019

Volltextzugriff (PDF)

Quantification of Designer Opioids by Liquid Chromatography-Tandem Mass Spectrometry

Methods in molecular biology (Clifton, N.J.), 2019, Vol.1872, p.149

2019

Volltextzugriff (PDF)

Reports of Adverse Events Associated with Use of Novel Psychoactive Substances, 2017-2020: A Review

Journal of analytical toxicology, 2022-07, Vol.46 (6), p.e116-e185

2022

Volltextzugriff (PDF)

4F‐MDMB‐BINACA: A New Synthetic Cannabinoid Widely Implicated in Forensic Casework

Journal of forensic sciences, 2019-09, Vol.64 (5), p.1451-1461

2019

Volltextzugriff (PDF)

Development and Validation of a Liquid Chromatography-Tandem Mass Spectrometry Method for the Identification and Quantification of JWH-018, JWH-073, JWH-019, and JWH-250 in Human Whole Blood

Journal of analytical toxicology, 2011-09, Vol.35 (7), p.386-393

2011

Volltextzugriff (PDF)

Rapid and sensitive screening and confirmation of thirty‐four aminocarbonyl/carboxamide (NACA) and arylindole synthetic cannabinoid drugs in human whole blood

Drug testing and analysis, 2017-06, Vol.9 (6), p.924-934

2017

Volltextzugriff (PDF)

“Bath Salts” and “Plant Food” Products: the Experience of One Regional US Poison Center

Journal of medical toxicology, 2013-03, Vol.9 (1), p.42-48

2013

Volltextzugriff (PDF)

Excretion of Methamphetamine and Amphetamine in Human Sweat Following Controlled Oral Methamphetamine Administration

Clinical chemistry (Baltimore, Md.), 2008-01, Vol.54 (1), p.172-180

2008

Volltextzugriff (PDF)

Case Series of Synthetic Cannabinoid Intoxication from One Toxicology Center

The western journal of emergency medicine, 2016-05, Vol.17 (3), p.290-294

2016

Volltextzugriff (PDF)

Validation and Application of a Method for the Determination of Buprenorphine, Norbuprenorphine, and Their Glucuronide Conjugates in Human Meconium

Analytical chemistry (Washington), 2008-01, Vol.80 (1), p.246-252

2008

Volltextzugriff (PDF)

Urinary Excretion of Buprenorphine, Norbuprenorphine, Buprenorphine-Glucuronide, and Norbuprenorphine-Glucuronide in Pregnant Women Receiving Buprenorphine Maintenance Treatment

Clinical chemistry (Baltimore, Md.), 2009-06, Vol.55 (6), p.1177-1187

2009

Volltextzugriff (PDF)

Disposition of Cocaine and Its Metabolites in Human Sweat after Controlled Cocaine Administration

Clinical chemistry (Baltimore, Md.), 2005-11, Vol.51 (11), p.2085-2094

2005

Volltextzugriff (PDF)

Development and validation of a liquid chromatography-tandem mass spectrometry assay for the simultaneous quantification of buprenorphine, norbuprenorphine, and metabolites in human urine

Analytical and bioanalytical chemistry, 2008-11, Vol.392 (5), p.903-911

2008

Volltextzugriff (PDF)

Opioid Disposition in Human Sweat after Controlled Oral Codeine Administration

Clinical chemistry (Baltimore, Md.), 2006-08, Vol.52 (8), p.1539-1545

2006

Volltextzugriff (PDF)

Brorphine—Investigation and quantitation of a new potent synthetic opioid in forensic toxicology casework using liquid chromatography‐mass spectrometr y

Journal of forensic sciences, 2021-03, Vol.66 (2), p.664-676

2021

Volltextzugriff (PDF)

Performance characteristics of the Cozart® RapiScan Oral Fluid Drug Testing System for opiates in comparison to ELISA and GC/MS following controlled codeine administration

Forensic science international, 2004-04, Vol.141 (1), p.41-48

2004

Volltextzugriff (PDF)

Coma, Seizures, Atrioventricular Block, and Hypoglycemia in an ADB-FUBINACA Body-Packer

The Journal of emergency medicine, 2018-12, Vol.55 (6), p.788-791

2018

Volltextzugriff (PDF)

Coma, seizures, AV block, and hypoglycemia in an ADB-FUBINACA body-packer

The Journal of emergency medicine, 2018-10, Vol.55 (6), p.788-791

2018

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Isotonitazene Quantitation and Metabolite Discovery in Authentic Forensic Casework

Analysis of Novel Synthetic Opioids U-47700, U-50488 and Furanyl Fentanyl by LC-MS/MS in Postmortem Casework

Brorphine—Investigation and quantitation of a new potent synthetic opioid in forensic toxicology casework using liquid chromatography‐mass spectrometry

Xylazine: Pharmacology Review and Prevalence and Drug Combinations in Forensic Toxicology Casework

Are Postmortem Cannabinoid Concentrations Forensically Reliable?

Reports of Adverse Events Associated with Use of Novel Psychoactive Substances, 2013–2016: A Review

Postmortem toxicology findings from the Camden Opioid Research Initiative

The Evolving Landscape of Designer Drugs

Quantification of Designer Opioids by Liquid Chromatography-Tandem Mass Spectrometry

Reports of Adverse Events Associated with Use of Novel Psychoactive Substances, 2017-2020: A Review

4F‐MDMB‐BINACA: A New Synthetic Cannabinoid Widely Implicated in Forensic Casework

Development and Validation of a Liquid Chromatography-Tandem Mass Spectrometry Method for the Identification and Quantification of JWH-018, JWH-073, JWH-019, and JWH-250 in Human Whole Blood

Rapid and sensitive screening and confirmation of thirty‐four aminocarbonyl/carboxamide (NACA) and arylindole synthetic cannabinoid drugs in human whole blood

“Bath Salts” and “Plant Food” Products: the Experience of One Regional US Poison Center

Excretion of Methamphetamine and Amphetamine in Human Sweat Following Controlled Oral Methamphetamine Administration

Case Series of Synthetic Cannabinoid Intoxication from One Toxicology Center

Validation and Application of a Method for the Determination of Buprenorphine, Norbuprenorphine, and Their Glucuronide Conjugates in Human Meconium

Urinary Excretion of Buprenorphine, Norbuprenorphine, Buprenorphine-Glucuronide, and Norbuprenorphine-Glucuronide in Pregnant Women Receiving Buprenorphine Maintenance Treatment

Disposition of Cocaine and Its Metabolites in Human Sweat after Controlled Cocaine Administration

Development and validation of a liquid chromatography-tandem mass spectrometry assay for the simultaneous quantification of buprenorphine, norbuprenorphine, and metabolites in human urine

Opioid Disposition in Human Sweat after Controlled Oral Codeine Administration

Brorphine—Investigation and quantitation of a new potent synthetic opioid in forensic toxicology casework using liquid chromatography‐mass spectrometr y

Performance characteristics of the Cozart® RapiScan Oral Fluid Drug Testing System for opiates in comparison to ELISA and GC/MS following controlled codeine administration

Coma, Seizures, Atrioventricular Block, and Hypoglycemia in an ADB-FUBINACA Body-Packer

Coma, seizures, AV block, and hypoglycemia in an ADB-FUBINACA body-packer

Suchergebnisse filtern